RU2017141446A - ENANTIOMERS OF 2-HYDROXY DERIVATIVE FATTY ACIDS - Google Patents
ENANTIOMERS OF 2-HYDROXY DERIVATIVE FATTY ACIDS Download PDFInfo
- Publication number
- RU2017141446A RU2017141446A RU2017141446A RU2017141446A RU2017141446A RU 2017141446 A RU2017141446 A RU 2017141446A RU 2017141446 A RU2017141446 A RU 2017141446A RU 2017141446 A RU2017141446 A RU 2017141446A RU 2017141446 A RU2017141446 A RU 2017141446A
- Authority
- RU
- Russia
- Prior art keywords
- cancer
- enantiomer
- pharmaceutically acceptable
- formula
- pathology
- Prior art date
Links
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical compound C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 title 1
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims 7
- 230000007170 pathology Effects 0.000 claims 5
- 108010022394 Threonine synthase Proteins 0.000 claims 4
- 102000004419 dihydrofolate reductase Human genes 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 230000002503 metabolic effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 230000006439 vascular pathology Effects 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000031229 Cardiomyopathies Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 206010020718 hyperplasia Diseases 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
- C07C51/493—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification whereby carboxylic acid esters are formed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Claims (16)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201131622 | 2011-10-07 | ||
ES201131622A ES2401629B1 (en) | 2011-10-07 | 2011-10-07 | ENANTIOMERS OF 2-HYDROXIDERIVATES OF FATTY ACIDS AND THEIR USE AS MEDICINES. |
US201261610762P | 2012-03-14 | 2012-03-14 | |
US61/610,762 | 2012-03-14 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2014118123A Division RU2637937C2 (en) | 2011-10-07 | 2012-10-08 | Enantiomers-2-hydroxy-derivatives of fatty acids |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2017141446A true RU2017141446A (en) | 2019-02-13 |
RU2017141446A3 RU2017141446A3 (en) | 2019-02-13 |
RU2687967C2 RU2687967C2 (en) | 2019-05-17 |
Family
ID=48043212
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017141446A RU2687967C2 (en) | 2011-10-07 | 2012-10-08 | Enantiomers of 2-hydroxy derivatives of fatty acids |
RU2014118123A RU2637937C2 (en) | 2011-10-07 | 2012-10-08 | Enantiomers-2-hydroxy-derivatives of fatty acids |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2014118123A RU2637937C2 (en) | 2011-10-07 | 2012-10-08 | Enantiomers-2-hydroxy-derivatives of fatty acids |
Country Status (12)
Country | Link |
---|---|
US (1) | US9359281B2 (en) |
EP (2) | EP3287437B1 (en) |
JP (1) | JP2014530806A (en) |
CN (1) | CN104321300A (en) |
DK (1) | DK2774910T3 (en) |
ES (3) | ES2401629B1 (en) |
HU (1) | HUE035430T2 (en) |
IN (1) | IN2014CN03111A (en) |
PL (1) | PL2774910T3 (en) |
PT (1) | PT2774910T (en) |
RU (2) | RU2687967C2 (en) |
WO (1) | WO2013050644A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2345241B1 (en) * | 2009-03-16 | 2011-09-08 | Lipopharma Therapeutics | USE OF 2-HYDROXIDERIVATES OF POLYINSATURATED FATTY ACIDS AS MEDICINES. |
RU2679443C2 (en) | 2014-10-21 | 2019-02-11 | Университат Де Лес Ильес Балеарс | Method for synthesis of hydroxy-triglycerides and uses thereof for prevention and treatment of diseases |
EP4234035A3 (en) * | 2017-05-16 | 2023-11-15 | Ability Pharmaceuticals S.A. | A pharmaceutical combination for the treatment of a cancer |
WO2019099664A1 (en) * | 2017-11-16 | 2019-05-23 | The Research Foundation For The State University Of New York | Use of 2-hydroxyoleic acid for the treatment of systemic lupus erythematosus and other immune pathologies |
ES2846824B2 (en) * | 2020-01-29 | 2022-01-19 | Univ Illes Balears | PRODRUGS OF POLYUNSATURATED FATTY ACIDS AND THEIR MEDICAL USES |
JP2023518640A (en) * | 2020-01-29 | 2023-05-08 | ウニバシタット デ レス イレス バレアース | Alpha-hydroxylated fatty acid metabolites, their medical uses and their use as biomarkers |
ES2911474B2 (en) * | 2020-11-17 | 2023-02-06 | Univ Illes Balears | PRODRUGS OF MONOUNSATURATED FATTY ACIDS AND THEIR METABOLITES: MEDICAL USES AND AS BIOMARKERS |
MX2022008623A (en) * | 2020-02-10 | 2022-08-08 | Ability Pharmaceuticals S L | A pharmaceutical combination for the treatment of a cancer. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2235541C2 (en) * | 1994-10-04 | 2004-09-10 | Эмори Юниверсити | Treatment of atherosclerosis and other cardio-vascular diseases |
AUPR547601A0 (en) * | 2001-06-05 | 2001-06-28 | Carcraft Qld Pty Ltd | Tab with writing surface |
ES2186576B1 (en) * | 2001-10-11 | 2004-09-16 | Universitat De Les Illes Balears | 2-HYDROXYOLEIC ACID TO USE AS A MEDICINAL PRODUCT. |
ES2342997B1 (en) * | 2008-12-09 | 2011-06-06 | Universitat De Les Illes Balears | ALPHA DERIVATIVES OF CIS-MONOINSATURATED FATTY ACIDS TO BE USED AS A MEDICINAL PRODUCT. |
ES2345241B1 (en) * | 2009-03-16 | 2011-09-08 | Lipopharma Therapeutics | USE OF 2-HYDROXIDERIVATES OF POLYINSATURATED FATTY ACIDS AS MEDICINES. |
-
2011
- 2011-10-07 ES ES201131622A patent/ES2401629B1/en active Active
-
2012
- 2012-10-08 IN IN3111CHN2014 patent/IN2014CN03111A/en unknown
- 2012-10-08 EP EP17191078.9A patent/EP3287437B1/en active Active
- 2012-10-08 EP EP12838506.9A patent/EP2774910B1/en active Active
- 2012-10-08 PL PL12838506T patent/PL2774910T3/en unknown
- 2012-10-08 ES ES12838506.9T patent/ES2653675T3/en active Active
- 2012-10-08 RU RU2017141446A patent/RU2687967C2/en active
- 2012-10-08 RU RU2014118123A patent/RU2637937C2/en not_active Application Discontinuation
- 2012-10-08 CN CN201280060748.XA patent/CN104321300A/en active Pending
- 2012-10-08 HU HUE12838506A patent/HUE035430T2/en unknown
- 2012-10-08 WO PCT/ES2012/070697 patent/WO2013050644A1/en active Application Filing
- 2012-10-08 JP JP2014533953A patent/JP2014530806A/en active Pending
- 2012-10-08 DK DK12838506.9T patent/DK2774910T3/en active
- 2012-10-08 US US14/349,962 patent/US9359281B2/en active Active
- 2012-10-08 PT PT128385069T patent/PT2774910T/en unknown
- 2012-10-08 ES ES17191078T patent/ES2773784T3/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104321300A (en) | 2015-01-28 |
EP3287437B1 (en) | 2019-12-11 |
DK2774910T3 (en) | 2018-01-08 |
RU2017141446A3 (en) | 2019-02-13 |
IN2014CN03111A (en) | 2015-07-03 |
ES2773784T3 (en) | 2020-07-14 |
EP3287437A1 (en) | 2018-02-28 |
EP2774910A1 (en) | 2014-09-10 |
PL2774910T3 (en) | 2018-03-30 |
WO2013050644A1 (en) | 2013-04-11 |
RU2014118123A (en) | 2015-11-20 |
HUE035430T2 (en) | 2018-05-02 |
ES2401629B1 (en) | 2014-03-04 |
US9359281B2 (en) | 2016-06-07 |
JP2014530806A (en) | 2014-11-20 |
US20140288176A1 (en) | 2014-09-25 |
EP2774910B1 (en) | 2017-09-27 |
RU2637937C2 (en) | 2017-12-08 |
PT2774910T (en) | 2018-01-03 |
EP2774910A4 (en) | 2015-02-25 |
ES2653675T3 (en) | 2018-02-08 |
RU2687967C2 (en) | 2019-05-17 |
ES2401629A1 (en) | 2013-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2017141446A (en) | ENANTIOMERS OF 2-HYDROXY DERIVATIVE FATTY ACIDS | |
RU2477723C2 (en) | Protein kinase inhibitor (versions), use thereof for treating oncological diseases and based pharmaceutical composition | |
CN103945848B (en) | The oral immediate release formulations of the quinazolinone being replaced | |
JP6595078B2 (en) | Aminocarbonyl carbamate compounds | |
RU2012112050A (en) | DERIVATIVES OF DIHYDROPERTERIDINONE, METHOD FOR PRODUCING THERE AND PHARMACEUTICAL USE | |
JP2013518050A5 (en) | ||
RU2014113679A (en) | N- (2-AMINO-6,6-DIFTOR-4,4A, 5,6,7,7A-HEXAHYDRO-CYCLOPENTA [E] [1,3] OXAZIN-4-IL) -PHENYL) -AMIDS AS INHIBITORS BETA SECRETASES 1 | |
EA201001159A1 (en) | Condensed Heterocyclic Derivatives and Their Application | |
RU2015100901A (en) | Heteroaryl Carboxylic Acid Derivatives | |
RU2017121460A (en) | Derivatives of pyridinecarboxamide, a method for their production and their pharmaceutical use | |
EA200601350A1 (en) | NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL APPLICATIONS | |
JP2018519340A (en) | Use of chloroquine and clemizole compounds to treat inflammatory and cancerous conditions | |
RU2011124894A (en) | C-MET TRIAZOLOTHYADIAZOL INHIBITOR | |
JP2016538281A5 (en) | ||
JP2008530242A5 (en) | ||
RU2013122898A (en) | Pohoxime conjugates applicable for the treatment of pathologies associated with the HSP90, composition and method of treatment using them | |
EA201390659A1 (en) | METHODS OF TREATMENT WITH THE APPLICATION OF LIPID COMPOUNDS | |
CN106795114A (en) | Novel iminonitrile derivative | |
JP2017533964A5 (en) | ||
RU2012135698A (en) | METHOD AND COMPOSITION | |
CA2933907A1 (en) | Selective hdac6 inhibitors | |
JP2015502371A5 (en) | ||
JP2016523830A (en) | Radiation mitigation pharmaceutical formulation | |
JP2016523830A5 (en) | ||
EP2772481A8 (en) | Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof |